HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SF 1126

an LY294002 prodrug and pan PI3K inhibitor; structure in first source
Also Known As:
SF-1126; SF1126
Networked: 17 relevant articles (2 outcomes, 8 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Durden, Donald L: 12 articles (01/2021 - 01/2008)
2. Joshi, Shweta: 8 articles (01/2021 - 01/2014)
3. Singh, Alok R: 7 articles (08/2017 - 01/2014)
4. Garlich, Joseph R: 4 articles (08/2017 - 01/2008)
5. Peirce, Susan K: 2 articles (09/2014 - 08/2011)
6. De, Pradip: 2 articles (04/2013 - 01/2008)
7. Dey, Nandini: 2 articles (04/2013 - 01/2008)
8. Goldin, Amanda N: 1 article (01/2021)
9. Jamieson, Christina: 1 article (01/2021)
10. Singh, Alok: 1 article (01/2021)

Related Diseases

1. Neoplasms (Cancer)
2. Neuroblastoma
3. Breast Neoplasms (Breast Cancer)
4. Hematologic Neoplasms (Hematological Malignancy)
5. Glioma (Gliomas)

Related Drugs and Biologics

1. Phosphatidylinositol 3-Kinases (PI 3 Kinase)
2. Prodrugs
3. Phosphotransferases (Kinase)
4. Proteasome Inhibitors
5. Vitronectin
6. Bortezomib (Velcade)
7. Trastuzumab (Herceptin)
8. Integrins
9. Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
10. Protein Isoforms (Isoforms)

Related Therapies and Procedures

1. Therapeutics
2. Subcutaneous Injections
3. Drug Therapy (Chemotherapy)